Core Viewpoint - The company plans to use its capital reserves to offset accumulated losses, aiming to improve its financial situation and meet profit distribution conditions as per legal and regulatory requirements [22][23][24]. Financial Data - The company reported a cumulative undistributed profit of -1,910,537,976.55 yuan as of December 31, 2024, with an ending balance of surplus reserves at 5,030,274.41 yuan and capital reserves at 2,260,280,858.86 yuan [22][23]. - The proposed plan involves using 5,030,274.41 yuan from surplus reserves and 1,905,507,702.14 yuan from capital reserves to offset the total accumulated losses [23][24]. Shareholder Meeting - The second extraordinary general meeting of shareholders is scheduled for November 12, 2025, with both on-site and online voting options available [11][13]. - The meeting will review the proposal to use capital reserves to offset losses, which has already been approved by the board of directors [29][31]. Corporate Governance - The board of directors has confirmed the authenticity and completeness of the financial reports and other disclosures, taking legal responsibility for the information provided [2][10]. - The board meeting held on October 27, 2025, approved the third-quarter report and the proposal for using capital reserves to offset losses, with unanimous support from all attending directors [27][29].
新疆百花村医药集团股份有限公司2025年第三季度报告